CBD: no risk to public health or abuse according to WHO
Consumption of the cannabidiol (CBD), a cannabinoid naturally produced by cannabis, is safe, well tolerated, and poses no risk to public health, according to the preliminary report of the World Health Organization (WHO) Expert Committee on Drug Dependence.
The authors of the report also state that CBD «has no potential for abuse» and does not lead to physical dependence. «CBD is generally well tolerated and has a good safety profile.».
Concerning therapeutic effects of CBD, the WHO reports that it «has been shown to be an effective treatment for epilepsy» and that there is «preliminary evidence that CBD may be a useful treatment for a number of other conditions,» including Alzheimer’s, cancer, Parkinson’s disease, and psychosis.
While the report notes that «unregulated medical use of CBD» in oils or extracts is relatively common, it states that «there is no evidence of recreational use of CBD or of health problems associated with the use of pure CBD.»
The WHO is currently considering investing in CBD on international lists of controlled substances. Following the review, which is expected to take place in May 2018, the use of CBD could be restricted—as THC is today—and limited to the medical sector.
-
Business1 week ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks ago
Which countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in the Netherlands4 weeks ago
One year after the launch of the Dutch cannabis experiment, the first trends are emerging
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164


You must be logged in to post a comment Login